following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
it shows that the longest waits for cancer treatment have soared since 2010..
the youngest claimant was aged 20, and the eldest aged 89, while the average policy duration at claim stage was 10 years..
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before.. print